Cava Group, Inc. (CAVA) insider trading.
In Q3 2026, insiders at Cava Group, Inc. reported 5 non-derivative transactions on 5 Forms 3, 4 and 5: 2 open-market purchases worth $482K and 0 sales.
- Transactions
- 5
- Purchases (P)
- 2
- Sales (S)
- 0
- Net shares, P minus S
- 7,500
- Insiders
- 4
- Last filed
- 2026-09-16
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Xenohristos Theodoros | Director, Officer · Chief Concept Officer | 2 | 0 | 0 |
| Kadow Joseph John | Officer · CLO & Secretary | 1 | 1 | 0 |
| Thompson Douglas W. | Officer · Chief Operations Officer | 1 | 1 | 0 |
| Thomas Amiee Lynn | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | Kadow Joseph John | P (A) | 1,000 | $49.96 | 1,000 | Form 4 |
| 2026-09-09 | Xenohristos Theodoros | G (A) | 16,500 | $0 | 16,500 | Form 4 |
| 2026-09-09 | Xenohristos Theodoros | G (D) | 16,500 | $0 | 308,130 | Form 4 |
| 2026-08-31 | Thompson Douglas W. | P (A) | 6,500 | $66.52 | 19,371 | Form 4 |
| 2026-08-13 | Thomas Amiee Lynn | A (A) | 1,821 | $0 | 1,821 | Form 4 |
Transaction codes in this quarter
Get CAVA insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1639438&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · CAVA company page · Cava Group, Inc. on SEC.gov
Questions
Are insiders buying or selling Cava Group, Inc. (CAVA)?
In Q3 2026, insiders at Cava Group, Inc. reported 5 non-derivative transactions on 5 Forms 3, 4 and 5: 2 open-market purchases worth $482K and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Cava Group, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/cava.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.